Regular Article
IL-6 Deficiency Leads to Reduced Metallothionein-I+II Expression and Increased Oxidative Stress in the Brain Stem after 6-Aminonicotinamide Treatment

https://doi.org/10.1006/exnr.2000.7383Get rights and content

Abstract

We examined the effects of interleukin-6 (IL-6) deficiency on brain inflammation and the accompanying bone marrow (BM) leukopoiesis and spleen immune reaction after systemic administration of a niacin antagonist, 6-aminonicotinamide (6-AN), which causes both astroglial degeneration/cell death in brain stem gray matter areas and BM toxicity. In both normal and genetically IL-6-deficient mice (IL-6 knockout (IL-6KO) mice), the extent of astroglial degeneration/cell death in the brain stem was similar as determined from disappearance of GFAP immunoreactivity. In 6-AN-injected normal mice reactive astrocytosis encircled gray matter areas containing astroglial degeneration/cell death, which were infiltrated by several macrophages and some T-lymphocytes. Reactive astrocytes and a few macrophages increased significantly the antioxidants metallothionein-I+II (MT-I+II) and moderately the MT-III isoform. In 6-AN-injected IL-6KO mice reactive astrocytosis and recruitment of macrophages and T-lymphocytes were clearly reduced, as were BM leukopoiesis and spleen immune reaction. Expression of MT-I+II was significantly reduced while MT-III was increased. Oxidative stress, as determined by measuring nitrated tyrosine and malondialdehyde, was increased by 6-AN to a greater extent in IL-6KO mice. The blood–brain barrier to albumin was only disrupted in 6-AN-injected normal mice, which likely is due to the substantial migration of blood-derived inflammatory cells into the CNS. The present results demonstrate that inflammation in CNS is clearly reduced during IL-6 deficiency and this effect is likely due to significant inhibition of BM leukopoiesis. We also show that IL-6 deficiency reduces the levels of neuroprotective antioxidants MT-I+II followed by an increased oxidative stress during CNS inflammation.

References (64)

  • L. Acarin et al.

    Expression of growth inhibitory factor (metallothionein-III) mRNA and protein following excitotoxic immature brain injury

    J. Neuropathol. Exp. Neurol.

    (1999)
  • L. Agullo et al.

    Metallothionein-I+II induction by zinc and copper in primary cultures of rat microglia

    Neurochem. Int.

    (1998)
  • T. Anezaki et al.

    Expression of growth inhibitory factor (GIF) in normal and injured rat brains

    Neurochem. Int.

    (1995)
  • M Aschner

    The functional significance of brain metallothioneins

    FASEB J.

    (1996)
  • M Aschner

    Astrocyte metallothioneins (MTs) and their neuroprotective role

    Ann. N.Y. Acad. Sci.

    (1997)
  • M. Aschner et al.

    Metallothioneins in brain—The role in physiology and pathology

    Toxicol. Appl. Pharmacol.

    (1997)
  • M Aschner

    Astrocytic functions and physiological reactions to injury: The potential to induce and/or exacerbate neuronal dysfunction—A forum position paper

    Neurotoxicology

    (1998)
  • M Aschner

    Metallothionein (MT) isoforms in the central nervous system (CNS): Regional and cell-specific distribution and potential functions as an antioxidant

    Neurotoxicology

    (1998)
  • F.M. Brett et al.

    Evolution of neuropathologic abnormalities associated with blood–brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes

    J. Neuropathol. Exp. Neurol.

    (1995)
  • R.D. Broadwell et al.

    Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood–brain barrier of blood-borne transferrin and antibody against the transferrin receptor

    Exp. Neurol.

    (1996)
  • R.D. Broadwell

    Endothelial cell biology and the enigma of transcytosis through the blood–brain barrier

    Adv. Exp. Med. Biol.

    (1993)
  • I.I. Budihardjo et al.

    6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin

    Clin. Cancer Res.

    (1998)
  • C.S. Chiang et al.

    Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice

    Dev. Neurosci.

    (1994)
  • T. Dalton et al.

    Temporalspatial patterns of expression of metallothionein-I and -III and other stress related genes in rat brain after kainic acid-induced seizures

    Neurochem. Int.

    (1995)
  • M. Eddleston et al.

    Molecular profile of reactive astrocytes-implications for their role in neurologic disease

    Neuroscience

    (1993)
  • J.C. Erickson et al.

    Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF)

    Brain Res.

    (1994)
  • T. Gasull et al.

    Development of a competitive double antibody radioimmunoassay for rat metallothionein

    J. Immunoassay

    (1993)
  • T. Dalton et al.

    Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements

    Nucleic Acids Res.

    (1994)
  • N. Haghignat et al.

    Effect of 6-aminonicotinamide on metabolism of astrocytes and C6-glioma cells

    Metabol. Brain Dis.

    (1996)
  • S.P. Hauser et al.

    The pivotal role of interleukin 6 in formation and function of hematopoietically active murine long-term bone marrow cultures

    Stem Cells

    (1997)
  • J. Hernandez et al.

    Endotoxin and intracerebroventricular injection of IL-1 and IL-6 induce rat brain metallothionein-I and -II

    Neurochem. Int.

    (1998)
  • J. Hernández et al.

    Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice

    Mol. Brain Res.

    (1997)
  • J. Hidalgo et al.

    Regulation of brain metallothioneins

    Curr. Top. Neurochem.

    (1997)
  • T. Hirano et al.

    Interleukin-6: Possible implications in human diseases

    Ric. Clin. Lab.

    (1989)
  • S. Hopkins et al.

    Cytokines and the nervous system. I. Expression and recognition

    Trends Neurosci.

    (1995)
  • I. Hozumi et al.

    Changes of growth inhibitory factor after stab wounds in rat brain

    Brain Res.

    (1995)
  • I. Hozumi et al.

    Brain injury and growth inhibitory factor (GIF)—A minireview

    Neurochem. Res.

    (1998)
  • J.S. Hothersall et al.

    Inhibition of NADPH supply by 6-aminonicotinamide: Effect on glutathione, nitric oxide and superoxide in J774 cells

    FEBS Lett.

    (1998)
  • T. Inuzuka et al.

    Patterns of growth inhibitory factor (GIF) and glial fibrillary acidic protein relative level changes differ following left middle cerebral artery occlusion in rats

    Brain Res.

    (1996)
  • M.A. Klein et al.

    Impaired neuroglial activation in interleukin-6 deficient mice

    Glia

    (1997)
  • Y. Kondo et al.

    Enhanced apoptosis in metallothionein null cells

    Mol. Pharmacol.

    (1997)
  • Cited by (51)

    • Interleukin-6: Its role and mechanisms in rescuing depression-like behaviors in rat models of depression

      2019, Brain, Behavior, and Immunity
      Citation Excerpt :

      In addition, we also found that knocking-down of IL-6 could increase the expression levels of pro-inflammatory cytokines such as the IL-1β, TNF-αand IFN-γ. It has been reported that IL-6 deficiency leads to increased oxidative stress and in the number of apoptotic neurons within the brain, as well as a delay in neural regeneration as compared with that observed in normal mice (Penkowa and Hidalgo, 2000; Penkowa et al., 2000). Thus, these results suggest that tissue damage induced by oxidative stress and apoptosis may result in the production of inflammatory cytokines via feedback mechanisms.

    • In vivo effect of acute exposure to interleukin-6 on the developing visual system

      2019, Neuroscience Letters
      Citation Excerpt :

      IL-6 levels are low in physiological conditions [5], but it increases in a number of pathological conditions [5–7]. IL-6 induces neuroprotection [8,9], regeneration of the optic nerve after crushing [10] and it is also important in the mechanism of axonal growth and recovery of function after injury [11,12]. Recently we had demonstrated that an acute intravitreal injection with IL-6 alters the laminar segregation of the uncrossed retinotectal pathway in different stages of development [13].

    • Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours

      2013, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      However, oxidative damage to IL-6ra subunits leads to decreased STAT-3 and subsequent M-SOD activity. Increased levels of IL-6 can prevent this oxidative damage in a stroke reperfusion model, possibly through modulating gene expression or up-regulating anti-oxidants (Penkowa and Hidalgo, 2000). In another recent study, two weeks of voluntary wheel running in mice protected against hippocampal dentate gyrus apoptosis induced by injection of trimethytin (TMT) (Funk et al., 2011), a substance known to induced cell death via TNF-α receptor activation (Harry et al., 2008).

    • Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury

      2011, Progress in Neurobiology
      Citation Excerpt :

      In the setting of TBI, IL6 has mostly been associated with neuroprotective actions. Using a cryolesion model and genetically manipulated mice, Penkowa and Hidalgo (2000) have described an impaired inflammatory response associated with increased neurodegeneration in IL6 deficient mice. In contrast, decreased oxidative stress and apoptotic cell death, together with increased healing and tissue repair were seen in transgenic mice overexpressing IL6 in astrocytes (Penkowa et al., 2003).

    • Immune and Inflammatory Responses in the Central Nervous System: Modulation by Astrocytes

      2008, NeuroImmune Biology
      Citation Excerpt :

      These mice show chronic neuroinflammation and neurodegeneration, and in the case of the IL-3 and TNF transgenic mice, demyelination and progressive motor disease are also seen [49,50]. In agreement with these in vivo models, it has been demonstrated that IL-6 protects neurons against ischemic damage and excitotoxicity [38–51]; yet, it is also largely responsible for the neuropathology associated with the multiple sclerosis (MS; Fig. 1) animal model, experimental autoimmune encephalomyelitis (EAE), since IL-6 KO mice are completely resistant to EAE [52–55]. Administration of the superantigen staphylococcal enterotoxin B, which acts through a TNF-receptor pathway, overcomes this resistance, but IL-6 is still considered crucial in perpetuating the disease [56].

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: +45-35327217. E-mail: [email protected].

    View full text